Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: Effects on acid-base status and phosphate supplementation needs

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Morabito, Santo ^a   Pistolesi, Valentina ^a   Tritapepe, Luigi ^a   Vitaliano, Elio ^b   Zeppilli, Laura ^a   Polistena, Francesca ^a   Fiaccadori, Enrico ^c   Pierucci, Alessandro ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SANDRO PERTINI HOSPITAL   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

AKI; Citrate; CRRT; CVVH; CVVHDF; Hypophosphatemia; Regional citrate anticoagulation

Indexed keywords

BICARBONATE; CALCIUM; CITRIC ACID; MAGNESIUM SULFATE; PHOSPHATE; PHOSPHORUS; POTASSIUM;

ACID BASE BALANCE; AGED; ALKALOSIS; ANTICOAGULANT THERAPY; ARTICLE; BICARBONATE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTINUOUS HEMODIAFILTRATION; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; DIALYSATE; ELECTROLYTE BLOOD LEVEL; FEMALE; FLOW RATE; HEART SURGERY; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; HYPOMAGNESEMIA; HYPOPHOSPHATEMIA; KIDNEY FUNCTION; LOW DRUG DOSE; MALE; METABOLIC ALKALOSIS; OBSERVATIONAL STUDY; PH; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; SUPPLEMENTATION; SURGICAL PATIENT;

ACUTE KIDNEY INJURY; AGED; ANTICOAGULANTS; CITRIC ACID; COMBINED MODALITY THERAPY; FEMALE; HEMOFILTRATION; HEMORRHAGE; HUMANS; HYDROGEN-ION CONCENTRATION; HYPOPHOSPHATEMIA; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; PHOSPHATES; PREMEDICATION; SOLUTIONS;

EID: 84887004130     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-232     Document Type: Article

References (44)

1. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten H, Ronco C, Kellum JA, Intensive Care Med 2007 33 1563 1570 10.1007/s00134-007-0754-4 17594074 (Pubitemid 47312485)
2. Dialysis in intensive care unit patients with acute kidney injury: continuous therapy is superior. Ronco C, Bellomo R, Clin J Am Soc Nephrol 2007 2 597 600 10.2215/CJN.00430107 17699468
3. Management of renal replacement therapy in ICU patients: an international survey. Legrand M, Darmon M, Joannidis M, Payen D, Intensive Care Med 2013 39 101 108 10.1007/s00134-012-2706-x 23001448
4. Anticoagulation during continuous renal replacement therapies. Mehta RL, ASAIO J 1994 40 931 935 7858328 (Pubitemid 24372217)
5. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. Van de Wetering J, Westendorp RG, van der Hoeven JG, Stolk B, Feuth JD, Chang PC, J Am Soc Nephrol 1996 7 145 150 8808122 (Pubitemid 26067101)
6. KDIGO clinical practice guideline for acute kidney injury. Kidney Disease Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group, Kidney Int 2012 2 Suppl 1 138
7. Incidence, risk factors, and prognosis of gastrointestinal hemorrhage complicating acute renal failure. Fiaccadori E, Maggiore U, Clima B, Melfa L, Rotelli C, Borghetti A, Kidney Int 2001 59 1510 1519 10.1046/j.1523-1755.2001. 0590041510.x 11260415 (Pubitemid 32281242)
8. Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit. Davenport A, Tolwani A, NDT Plus 2009 2 439 447 10.1093/ndtplus/sfp136
9. Clinical review: anticoagulation for continuous renal replacement therapy-heparin or citrate? Oudemans-van Straaten HM, Kellum JA, Bellomo R, Crit Care 2011 15 202 21345279
10. Regional citrate anticoagulation: towards a first-choice treatment. Morabito S, Pistolesi V, Pierucci A, G Ital Nefrol 2012 29 14 19 22388901
11. Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Zhang Z, Hongying N, Intensive Care Med 2012 38 20 28 10.1007/s00134-011-2438-3 22124775
12. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Wu MY, Hsu YH, Bai CH, Lin YF, Wu CH, Tam KW, Am J Kidney Dis 2012 59 810 818 10.1053/j.ajkd.2011.11.030 22226564
13. Bench-to-bedside review: citrate for continuous renal replacement therapy, from science to practice. Oudemans-van Straaten HM, Ostermann M, Crit Care 2012 16 249 10.1186/cc11645 23216871
14. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P, Intensive Care Med 2004 30 260 265 10.1007/s00134-003-2047-x 14600809 (Pubitemid 38253417)
15. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kutsogiannis DJ, Gibney RT, Stollery D, Gao J, Kidney Int 2005 67 2361 2367 10.1111/j.1523-1755.2005.00342.x 15882280 (Pubitemid 41623398)
16. Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding. Betjes MG, van Oosterom D, van Agteren M, van de Wetering J, J Nephrol 2007 20 602 608 17918147
17. Citrate anticoagulation for continuous venovenous hemofiltration. Oudemans-van Straaten HM, Bosman RJ, Koopmans M, van der Voort PH, Wester JP, van der Spoel JI, Dijksman LM, Zandstra DF, Crit Care Med 2009 37 545 552 10.1097/CCM.0b013e3181953c5e 19114912
18. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Hetzel GR, Schmitz M, Wissing H, Ries W, Schott G, Heering PJ, Isgro F, Kribben A, Himmele R, Grabensee B, Rump LC, Nephrol Dial Transplant 2011 26 232 239 10.1093/ndt/gfq575 20876598
19. Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution. Morabito S, Pistolesi V, Tritapepe L, Zeppilli L, Polistena F, Strampelli E, Pierucci A, Crit Care 2012 16 111 10.1186/cc11403 22738289
20. Anticoagulation in continuous renal replacement therapy. Abramson S, Niles JL, Curr Opin Nephrol Hypertens 1999 8 701 707 10.1097/00041552-199911000- 00009 10630816 (Pubitemid 30029467)
21. Blood and ultrafiltrate dosage of citrate as a useful and routine tool during continuous venovenous haemodiafiltration in septic shock patients. Mariano F, Morselli M, Bergamo D, Hollo Z, Scella S, Maio M, Tetta C, Dellavalle A, Stella M, Triolo G, Nephrol Dial Transplant 2011 26 3882 3888 10.1093/ndt/gfr106 21385861
22. A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance. Tolwani AJ, Prendergast MB, Speer RR, Stofan BS, Wille KM, Clin J Am Soc Nephrol 2006 1 79 87 17699194
23. A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Morgera S, Schneider M, Slowinski T, Vargas-Hein O, Zuckermann-Becker H, Peters H, Kindgen-Milles D, Neumayer HH, Crit Care Med 2009 37 2018 2024 10.1097/CCM.0b013e3181a00a92 19384210
24. Regional citrate anticoagulation in CVVH: a new protocol combining citrate solution with a phosphate-containing replacement fluid. Morabito S, Pistolesi V, Tritapepe L, Zeppilli L, Polistena F, Fiaccadori E, Pierucci A, Hemodial Int 2013 17 313 320 10.1111/j.1542-4758.2012.00730.x 22882732
25. Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy. Troyanov S, Geadah D, Ghannoum M, Cardinal J, Leblanc M, Intensive Care Med 2004 30 1662 1665 15156308 (Pubitemid 39094971)
26. Intensity of renal support in critically ill patients with acute kidney injury. Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P, VA/NIH Acute Renal Failure Trial Network, N Engl J Med 2008 359 7 20 18492867 (Pubitemid 351931092)
27. Intensity of continuous renal-replacement therapy in critically ill patients. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S, RENAL Replacement Therapy Study Investigators, N Engl J Med 2009 361 1627 1638 19846848
28. Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children. Santiago MJ, López-Herce J, Urbano J, Bellón JM, del Castillo J, Carrillo A, Kidney Int 2009 75 312 316 10.1038/ki.2008.570 19002217
29. Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Demirjian S, Teo BW, Guzman JA, Heyka RJ, Paganini EP, Fissell WH, Schold JD, Schreiber MJ, Nephrol Dial Transplant 2011 26 3508 3514 10.1093/ndt/gfr075 21382993
30. Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy. Broman M, Carlsson O, Friberg H, Wieslander A, Godaly G, Acta Anaesthesiol Scand 2011 55 39 45 10.1111/j.1399-6576.2010.02338.x 21039362
31. Biochemical effects of phosphate-containing replacement fluid for continuous venovenous hemofiltration. Chua HR, Baldwin I, Ho L, Collins A, Allsep H, Bellomo R, Blood Purif 2012 34 306 312 10.1159/000345343 23235269
32. Permeability of human and rat red blood cells to citrate. Whitfield LR, Levy G, Thromb Res 1981 21 681 684 10.1016/0049-3848(81)90270-X 7268706 (Pubitemid 11117861)
33. Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation. Kozik-Jaromin J, Nier V, Heemann U, Kreymann B, Bohler J, Nephrol Dial Transplant 2009 24 2244 2251 10.1093/ndt/gfp017 19196824
34. Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration. Hetzel GR, Taskaya G, Sucker C, Hennersdorf M, Grabensee B, Schmitz M, Am J Kidney Dis 2006 48 806 811 10.1053/j.ajkd.2006.07.016 17060000 (Pubitemid 44740041)
35. Normal citratemia and metabolic tolerance of citrate anticoagulation for hemodiafiltration in severe septic shock burn patients. Mariano F, Tedeschi L, Morselli M, Stella M, Triolo G, Intensive Care Med 2010 36 1735 1743 10.1007/s00134-010-1909-2 20480135
36. Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionised and total/ionised calcium. Bakker AJ, Boerma EC, Keidel H, Kingma P, van der Voort PH, Clin Chem Lab Med 2006 44 962 966 16879061 (Pubitemid 44155864)
37. Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study. Schultheiß C, Saugel B, Phillip V, Thies P, Noe S, Mayr U, Haller B, Einwachter H, Schmid RM, Huber W, Crit Care 2012 16 162 10.1186/cc11485 22913794
38. Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients. Link A, Klingele M, Speer T, Rbah R, Poss J, Lerner-Graber A, Fliser D, Bohm M, Crit Care 2012 16 97 10.1186/cc11363 22643456
39. Regional citrate anticoagulation in predilution continuous venovenous hemofiltration using prismocitrate 10/2 solution. Shum HP, Chan KC, Yan WW, Ther Apher Dial 2012 16 81 86 10.1111/j.1744-9987.2011.01001.x 22248200
40. Metabolic effects of citrate- vs bicarbonate-based substitution fluid in continuous venovenous hemofiltration: a prospective sequential cohort study. Aman J, Nurmohamed SA, Vervloet MG, Groeneveld AB, J Crit Care 2010 25 120 127 10.1016/j.jcrc.2009.02.013 19427760
41. Continuous venovenous haemofiltration with citrate-buffered replacement solution is safe and efficacious in patients with a bleeding tendency: a prospective observational study. Nurmohamed SA, Jallah BP, Vervloet MG, Yldirim G, ter Wee PM, Groeneveld AB, BMC Nephrol 2013 14 89 10.1186/1471-2369-14-89 23597045
42. Nutritional evaluation and management of AKI patients. Fiaccadori E, Maggiore U, Cabassi A, Morabito S, Castellano G, Regolisti G, J Ren Nutr 2013 23 255 258 10.1053/j.jrn.2013.01.025 23489867
43. Hypophosphatemia in critically ill patients. Suzuki S, Egi M, Schneider AG, Bellomo R, Hart GK, Hegarty C, J Crit Care 2013 28 536
44. Hypophosphataemia. Pathophysiology, effects and management on the intensive care unit. Bugg NC, Jones JA, Anaesthesia 1998 53 895 902 10.1046/j.1365-2044.1998.00463.x 9849285 (Pubitemid 28431598)